Abstract
Mucinous pancreatic cysts are now common incidental findings with the increased use and higher resolution of modern cross-sectional imaging, and surgeons are faced with the challenge of identifying those patients with premalignant or malignant lesions from those lesions with little chance of ever impacting patient survival. The risks of selecting to observe mucinous cystic lesions should be balanced against the morbidity and mortality of pancreatic resection, particularly when located in the head of the pancreas. Currently, the criteria for resection are based mainly on morphologic features or abnormal cytological findings. Most of the controversy revolves around the management of small branch-duct IPMN, given its relatively low malignant potential, high prevalence in older patients, and tendency to appear in the head of the gland. Thick/enhanced cyst wall, dilation of the pancreatic duct and mural nodules are consistent predictors of malignancy, while size alone remains controversial and a subject for continued debate.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Brugge WR, Lauwers GY, Sahani D, et al. Cystic neoplasms of the pancreas. N Engl J Med. 2004;351:1218–26.
Crippa S, Salvia R, Warshaw AL, et al. Mucinous cystic neoplasm of the pancreas is not an aggressive entity. Lessons from 163 resected patients. Ann Surg. 2008;247:571–9.
Nagula S, Kennedy T, Schattner MA, et al. Evaluation of cyst fluid CEA analysis in the diagnosis of mucinous cysts of the pancreas. J Gastrointest Surg. 2010;14:1997–2003.
Kobari M, Egawa S, Shibuya K, et al. Intraductal papillary mucinous tumors of the pancreas comprise 2 clinical subtypes: differences in clinical characteristics and surgical management. Arch Surg. 1999;134:1131–6.
Torris B, Ponsot P, Paye F, et al. Intraductal papillary mucinous tumors of the pancreas confined to secondary ducts show less aggressive pathologic features as compared with those involving the main pancreatic duct. Am J Surg Pathol. 2000;24:1372–7.
Doi R, Fujimoto K, Wada M, et al. Surgical management of intraductal papillary mucinous tumor of the pancreas. Surgery. 2002;132:80–5.
Matsumoto T, Aramaki M, Yada K, et al. Optimal management of the branch duct type intraductal papillary mucinous neoplasm of the pancreas. J Clin Gastroenterol. 2003;36:261–5.
Choi BS, Kim TK, Kim AY, et al. Differential diagnosis of benign and malignant intraductal papillary mucinous tumors of the pancreas: MR cholangio-pancreatography and MR angiography. Korean J Radiol. 2003;4:157–62.
Kitagawa Y, Unger TA, Taylor S, et al. Mucus is a predictor of better prognosis and survival in patients with intraductal papillary mucinous tumor of the pancreas. J Gastrointest Surg. 2003;7:12–9.
Sugiyama M, Izumisato Y, Abe N. Predictive factors for malignancy in intraductal papillary-mucinous tumors of the pancreas. Br J Surg. 2003;90:1244–9.
Sohn TA, Yeo CJ, Cameron JL, et al. Intraductal papillary mucinous neoplasms of the pancreas: an updated experience. Ann Surg. 2004;239:788–99.
Salvia R, Fernandez-del Castillo C, Basi C, et al. Main duct intraductal papillary mucinous neoplasms of the pancreas: clinical predictors of malignancy and long-term survival following resection. Ann Surg. 2004;239:678–87.
Wada K, Takada T, Yasuda H, et al. Does “clonal progression” relate to the development of intraductal papillary mucinous tumors of the pancreas? J Gastrointest Surg. 2004;8:289–96.
Chari S, Yadav D, Smyrk TC, et al. Study of recurrence after surgical resection of intraductal papillary mucinous neoplasm of the pancreas. Gastroenterology. 2002;123:1500–7.
Tanaka M, Chari S, Adsay V, et al. International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas. Pancreatology. 2006;6:17–32.
Pelaez-Luna M, Chari ST, Smyrk TC, et al. Do consensus indications for resection in branch duct intraductal papillary mucinous neoplasm predict malignancy? A study of 147 patients. Am J Gastroenterol. 2007;102:1759–64.
Tang RS, Weinberg B, Dawson DW, et al. Evaluation of the guidelines for management of pancreatic branch-duct intraductal papillary mucinous neoplasm. Clin Gastroenterol Hepatol. 2008;6:815–9.
Nagai K, Doi R, Ito T, et al. Single-institution validation of the international consensus-guidelines for treatment of branch duct intraductal papillary mucinous neoplasms of the pancreas. J Hepatobiliary Pancreat Surg. 2009;16:353–8.
Tanaka M, Fernandez-del Castillo C, Adsay V, et al. International consensus guidelines 2012 for the management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas. Pancreatology. 2012;12:183–97.
Kang MJ, Jang JY, Kim SJ, et al. Cyst growth rate predicts malignancy in patients with branch duct intraductal papillary mucinous neoplasms. Clin Gastroenterol Hepatol. 2011;9:87–93.
Levy P, Jouannaud V, O’Toole D, et al. Natural history of intraductal papillary mucinous tumors of the pancreas: actuarial risk of malignancy. Clin Gastroenterol Hepatol. 2006;4:460–8.
Weinberg BM, Spiegel BM, Tomlinson JS, Farrell JJ. Asymptomatic pancreatic cystic neoplasms: maximizing survival and quality of life using Markov-based clinical nomograms. Gastroenterology. 2010;138:531–40.
Fritz S, Klauss M, Bergmann F, et al. Small (Sendai negative) branch-duct intraductal papillary mucinous neoplasms. Not harmless. Ann Surg. 2012;256:313–20.
Wong J, Weber J, Centeno BA, et al. High-grade dysplasia and adenocarcinoma are frequent in side-branch intraductal papillary mucinous neoplasm measuring less than 3 cm on endoscopic ultrasound. J Gastrointest Surg. 2012;17:78–85.
Anand NJ, Sampath K, Wu BU. Cyst features and risk of malignancy in intraductal papillary mucinous neoplasms of the pancreas: a meta-analysis. Clin Gastroenterol Hepatol. 2013;11:913–21.
Sahora K, Mino-Kenudson M, Brugge W, et al. Branch duct intraductal papillary mucinous neoplasms. Does cyst size change the tip of the scale? A critical analysis of the revised International Consensus Guidelines in a large single-institutional series. Ann Surg. 2013;258:466–75.
Yeo CJ, Cameron JL, Sohn TA, et al. Six hundred fifty consecutive pancreaticoduodenectomies in the 1990s. Pathology, complications and outcomes. Ann Surg. 1997;226:248–60.
Fong Y, Gonen M, Rubin D, et al. Long-term survival is superior after resection for cancer in high-volume centers. Ann Surg. 2005;242:540–7.
Reddy RP, Smyrk TC, Zapiach M, et al. Pancreatic mucinous cystic neoplasm defined by ovarian stroma: demographics, clinical features, and prevalence of cancer. Clin Gastroenterol Hepatol. 2004;2:1026–31.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Barreto, J.C., Posner, M.C. (2016). Surgery or Surveillance for Asymptomatic Small Mucinous Pancreatic Head Cyst. In: Millis, J., Matthews, J. (eds) Difficult Decisions in Hepatobiliary and Pancreatic Surgery. Difficult Decisions in Surgery: An Evidence-Based Approach. Springer, Cham. https://doi.org/10.1007/978-3-319-27365-5_46
Download citation
DOI: https://doi.org/10.1007/978-3-319-27365-5_46
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-27363-1
Online ISBN: 978-3-319-27365-5
eBook Packages: MedicineMedicine (R0)